Deutsche Bank Portfolio holdings
Deutsche Bank AG, founded in 1870 to finance German exports and headquartered in Frankfurt, Germany, is a leading global investment bank with a significant presence in commercial banking, wealth management, and asset management, managing billions in assets across Europe, the Americas, and Asia. Known for its expertise in trading, corporate finance, and mergers and acquisitions, it serves corporations, governments, and institutional clients, though it has faced challenges, including hefty fines and restructuring efforts following the 2008 financial crisis and subsequent scandals. Under CEO Christian Sewing since 2018, the bank has shifted focus toward cost-cutting, digital transformation, and strengthening its core European operations, while its asset management arm, DWS, oversees hundreds of billions in investments. Despite a turbulent past, Deutsche Bank remains a key player in global finance, balancing its legacy with efforts to adapt to a rapidly evolving industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$554M |
| 2 |
Chevron
CVX
|
+$299M |
| 3 |
Visa
V
|
+$286M |
| 4 |
JPMorgan Chase
JPM
|
+$285M |
| 5 |
ExxonMobil
XOM
|
+$256M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Verizon
VZ
|
+$459M |
| 2 |
Apple
AAPL
|
+$345M |
| 3 |
FTCH
Farfetch Limited Class A Ordinary Shares
FTCH
|
+$243M |
| 4 |
AbbVie
ABBV
|
+$222M |
| 5 |
Cisco
CSCO
|
+$218M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.59% |
| 2 | Healthcare | 12.96% |
| 3 | Financials | 12.39% |
| 4 | Consumer Discretionary | 9.69% |
| 5 | Communication Services | 9.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1901
Visteon
VC
$2.81B
| $2.63M | ﹤0.01% |
21,556
-1,799
| -8% | -$236K |
|
1902
Myriad Genetics
MYGN
$303M
| $2.63M | ﹤0.01% |
86,255
-11,384
| -12% | -$323K |
|
1903
Wolfspeed
WOLF
$1.41B
| $2.62M | ﹤0.01% |
24,266
+14,059
| +138% | +$1.58M |
|
1904
Houlihan Lokey
HLI
$8.96B
| $2.62M | ﹤0.01% |
39,416
-8,732
| -18% | -$589K |
|
|
GOOS
1905
Canada Goose Holdings
GOOS
$860M
| $2.61M | ﹤0.01% |
66,505
+34,883
| +110% | +$1.38M |
|
1906
LivaNova
LIVN
$4.69B
| $2.61M | ﹤0.01% |
35,399
-3,168
| -8% | -$226K |
|
1907
Avista
AVA
$3.28B
| $2.61M | ﹤0.01% |
54,576
-159,093
| -74% | -$6.55M |
|
|
CMBT
1908
CMB.TECH NV
CMBT
$4.62B
| $2.6M | ﹤0.01% |
284,691
+154,115
| +118% | +$1.36M |
|
|
TRHC
1909
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
| $2.6M | ﹤0.01% |
56,492
-22,639
| -29% | -$1.08M |
|
|
NUVA
1910
DELISTED
NuVasive, Inc.
NUVA
| $2.6M | ﹤0.01% |
39,588
-2,446
| -6% | -$147K |
|
1911
Armstrong World Industries
AWI
$7.74B
| $2.59M | ﹤0.01% |
28,772
-203
| -0.7% | -$17.2K |
|
|
OPI
1912
DELISTED
Office Properties Income Trust
OPI
| $2.59M | ﹤0.01% |
94,193
+44,670
| +90% | +$1.16M |
|
|
ALPN
1913
DELISTED
Alpine Immune Sciences Inc
ALPN
| $2.59M | ﹤0.01% |
+244,332
| New | +$3.05M |
|
1914
State Street SPDR S&P Biotech ETF
XBI
$9.92B
| $2.59M | ﹤0.01% |
19,063
| – | – |
|
|
NTUS
1915
DELISTED
Natus Medical Inc
NTUS
| $2.58M | ﹤0.01% |
100,794
-31,896
| -24% | -$818K |
|
1916
Westamerica Bancorp
WABC
$1.39B
| $2.57M | ﹤0.01% |
40,981
+17,957
| +78% | +$1.09M |
|
|
LUXE
1917
LuxExperience B.V.
LUXE
$1.16B
| $2.57M | ﹤0.01% |
+90,885
| New | +$2.81M |
|
1918
Immunovant
IMVT
$8.08B
| $2.57M | ﹤0.01% |
159,946
+128,765
| +413% | +$3.4M |
|
|
QUOT
1919
DELISTED
Quotient Technology Inc
QUOT
| $2.57M | ﹤0.01% |
157,038
+92,451
| +143% | +$1.14M |
|
|
OCDX
1920
DELISTED
Ortho Clinical Diagnostics Holdings plc Ordinary Shares
OCDX
| $2.56M | ﹤0.01% |
+132,919
| New | +$2.34M |
|
1921
Editas Medicine
EDIT
$425M
| $2.56M | ﹤0.01% |
61,038
+7,974
| +15% | +$454K |
|
|
BBBY
1922
DELISTED
Bed Bath & Beyond Inc
BBBY
| $2.56M | ﹤0.01% |
87,859
-33,772
| -28% | -$945K |
|
1923
Gates Industrial Corporation Ltd.
GTES
$7.55B
| $2.56M | ﹤0.01% |
160,099
+131,195
| +454% | +$2.03M |
|
|
CARM
1924
DELISTED
Carisma Therapeutics
CARM
| $2.55M | ﹤0.01% |
49,021
+47,717
| +3,659% | +$2.25M |
|
1925
Enova International
ENVA
$6.42B
| $2.55M | ﹤0.01% |
71,815
+47,532
| +196% | +$1.42M |
|
Similar funds
Deutsche Bank's Q1 2021 Portfolio in Review
As of Q1 2021, Deutsche Bank held 4,832 positions worth $186B, up 13% from $164B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Deutsche Bank deployed $12.1B of net new capital in Q1 2021, opening 392 new positions and adding to 1,770 existing holdings. Its largest new stake was Ferguson: 746,157 shares worth $89.6M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Verizon, an estimated $459M trimmed.
- Deutsche Bank's largest Q1 2021 buy was Ferguson: 746,157 shares worth $89.6M.
- Deutsche Bank added most to Microsoft in Q1 2021, an estimated $554M increase.
- Deutsche Bank's biggest Q1 2021 reduction was Verizon, cutting an estimated $459M.
- Deutsche Bank fully exited Tiffany & Co. in Q1 2021, selling an estimated $41.2M.
- Deutsche Bank's ten largest holdings make up 19% of its $186B portfolio in Q1 2021.
- Deutsche Bank opened 392 new positions and closed 268 in Q1 2021.
- Deutsche Bank's portfolio value rose 13% quarter-over-quarter to $186B.
Based on Deutsche Bank's 13F filing for Q1 2021, filed 13 May 2021.